---
figid: PMC4407294__13058_2015_560_Fig1_HTML
figlink: /pmc/articles/PMC4407294/figure/Fig1/
number: F1
caption: The PI3K/AKT/mTOR and the RAS/RAF/MEK/MAPK pathways. Phosphoinositide 3-kinase
  (PI3K) is a cytoplasmic lipid and protein kinase recruited to the membrane by activated
  growth factor receptors, including human epidermal growth factor receptor 2 (HER2),
  epidermal growth factor receptor (EGFR), and insulin-like growth factor 1 (IGF-1R).
  PI3K phosphorylates the 3′-hydroxyl group of phosphoinositides to produce phoshatidylinositol-3,4,5-trisphosphate
  (PIP3), which is a second messenger that signals through AKT to activate several
  enzymes, kinases, and transcription factors, including mammalian target of rapamycin
  (mTOR). The RAS/RAF/MEK/MAPK pathway converges with the PI3K/AKT pathway and is
  now recognized as an alternative in mTOR activation. On the other hand, phosphatase
  and tensin homolog (PTEN) catalyzes PIP3 dephosphorylation, acting as a negative
  regulator of its activity. In parallel with activation of growth factor receptors,
  estrogens can activate nuclear estrogen receptors (ERs) (genomic pathway) or ERs
  on the membrane (non-genomic pathway). Membrane-associated ER binds to PI3K and
  activates molecules such as AKT and RAS, crosstalking with the growth factor signaling
  pathways. Erk1/2, extracellular-signal-regulated kinase 1/2; FOXO1, Forkhead box
  protein O1; MEK1/2, MAPK/Erk kinase 1/2; PIP, phosphatidylinositol phosphate; Raf,
  murine sarcoma viral oncogene homolog; Ras, rat sarcoma viral oncogene homolog;
  RHEB, Ras homolog enriched in brain; RTK, receptor tyrosine kinase; TSC1/2, tuberous
  sclerosis proteins 1 and 2.
pmcid: PMC4407294
papertitle: Molecular characterization and targeted therapeutic approaches in breast
  cancer.
reftext: Angela Toss, et al. Breast Cancer Res. 2015;17(1):60.
pmc_ranked_result_index: '83332'
pathway_score: 0.960759
filename: 13058_2015_560_Fig1_HTML.jpg
figtitle: PI3K/AKT/mTOR and the RAS/RAF/MEK/MAPK pathways
year: '2015'
organisms:
- Homo sapiens
ndex: b074d3ef-ded8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4407294__13058_2015_560_Fig1_HTML.html
  '@type': Dataset
  description: The PI3K/AKT/mTOR and the RAS/RAF/MEK/MAPK pathways. Phosphoinositide
    3-kinase (PI3K) is a cytoplasmic lipid and protein kinase recruited to the membrane
    by activated growth factor receptors, including human epidermal growth factor
    receptor 2 (HER2), epidermal growth factor receptor (EGFR), and insulin-like growth
    factor 1 (IGF-1R). PI3K phosphorylates the 3′-hydroxyl group of phosphoinositides
    to produce phoshatidylinositol-3,4,5-trisphosphate (PIP3), which is a second messenger
    that signals through AKT to activate several enzymes, kinases, and transcription
    factors, including mammalian target of rapamycin (mTOR). The RAS/RAF/MEK/MAPK
    pathway converges with the PI3K/AKT pathway and is now recognized as an alternative
    in mTOR activation. On the other hand, phosphatase and tensin homolog (PTEN) catalyzes
    PIP3 dephosphorylation, acting as a negative regulator of its activity. In parallel
    with activation of growth factor receptors, estrogens can activate nuclear estrogen
    receptors (ERs) (genomic pathway) or ERs on the membrane (non-genomic pathway).
    Membrane-associated ER binds to PI3K and activates molecules such as AKT and RAS,
    crosstalking with the growth factor signaling pathways. Erk1/2, extracellular-signal-regulated
    kinase 1/2; FOXO1, Forkhead box protein O1; MEK1/2, MAPK/Erk kinase 1/2; PIP,
    phosphatidylinositol phosphate; Raf, murine sarcoma viral oncogene homolog; Ras,
    rat sarcoma viral oncogene homolog; RHEB, Ras homolog enriched in brain; RTK,
    receptor tyrosine kinase; TSC1/2, tuberous sclerosis proteins 1 and 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TSC2
  - RHEB
  - HRAS
  - TSC1
  - GSK3B
  - MAPK3
  - MAPK1
  - RPTOR
  - ARAF
  - RAF1
  - NRAS
  - AKT1
  - AKT2
  - ERBB2
  - PIK3R5
  - PIK3R4
  - FOXO1
  - PIK3CD
  - GSK3A
  - MTOR
  - MAP2K2
  - BRAF
  - AKT3
  - MLST8
  - MAPKAP1
  - PIK3R6
  - PIK3CG
  - MAP2K1
  - PTEN
  - PIK3CA
  - KRAS
  - RICTOR
  - PIK3R3
  - PIK3CB
  - Glucose
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: RHEB
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: GSK3A/B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Erk1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Erk1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGRF/HER2)
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: GSK3A/B
  symbol: GSK3A
  source: hgnc_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4407294__F1
redirect_from: /figures/PMC4407294__F1
figtype: Figure
---
